A national, prospective observational study of the first recurrence after primary treatment for gynecological cancer in Norway
Acta Obstetricia et Gynecologica Scandinavica Aug 14, 2017
Vistad I, et al. – Here, researchers prospectively researched time to first recurrence, symptoms at recurrence, diagnostic procedures, and recurrence treatment in gynecological cancer patients after primary curative treatment. The current study showed that the majority of patients experienced symptomatic recurrence, but many patients failed to make an appointment earlier than scheduled. Most first recurrences occurred within 2 years of primary treatment; the mean annual incidence rate for years 3–5 after primary treatment was <7%. New models for follow–up of gynecological cancer patients could be considered.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries